Skip to content
vaccines hero image
vaccines hero image

Vaccines

Vaccines contain antigenic substances capable of inducing immunity against an infective agent or toxin.

They are frequently administered prophylactically but are increasingly being researched and developed in a therapeutic context (eg cancer vaccines which are designed to equip a patient’s immune system to treat an existing cancer).

While the global market for vaccines is less than 3% of the total pharmaceuticals market, World Health Organization research suggests that over the next few years, the vaccine market will enjoy a growth rate of 10% to 15% per year versus the 5% to 7% seen in the overall market.

To take a share of this expanding market, companies must navigate a number of challenges. The assessment, licensing and control of vaccines (which are biological medicinal products) occurs in an environment of rapid innovation and complex quality concerns. Our deep experience of vaccines, combined with the fact that our team includes lawyers with degrees in relevant scientific areas (molecular biology, biochemistry, genetics etc), enables us to quickly grasp evolving issues and technical concepts and provide nuanced and tailored advice.

We are trusted by many of the world’s leading vaccine companies to help them navigate all stages of the vaccine lifecycle. Our clients include Merck, GlaxoSmithKline, Johnson & Johnson, Pfizer and Novartis.

News & Insights

Impfdosen

Publications: 03 MARCH 2021

#Employmenttalk: Impfen

Nach sieben Ausgaben unserer Client Call-Serie rund um das Themengebiet Covid-19 möchten wir nun auf das Thema Impfen im Detail eingehen.

Lesen Sie mehr
Online Gesundheitsportal

News: 11 FEBRUARY 2021

Allen & Overy begleitet Tochter der französischen Fernsehsendergruppe TF1 bei Verkauf von Gesundheitsportal Onmeda.de an FUNKE Medien

Allen & Overy hat die zur französischen Medienholding Groupe TF1 und deren Segment Unify gehörende gofeminin.de GmbH aus Köln beim Verkauf des Gesundheitsportals Onmeda.de an die FUNKE Mediengruppe…

Lesen Sie mehr
Covid-19

Publications: 26 MARCH 2020

Covid-19 Coronavirus: Änderung des Infektionsschutzgesetzes des Bundes

Nachdem die bayerische Staatsregierung bereits letzte Woche Pläne verlauten ließ, ein bayerisches Infektionsschutzgesetz zu erlassen, das ausreichende Grundlagen schaffen sollte, um im Notfall die…

Lesen Sie mehr

Download our sector brochure

An insight in to our Life Science and Healthcare sector 2021

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.